Olink

Olink®
Part of Thermo Fisher Scientific

The European Association for Cancer Research (EACR) Congress

Event details

Date

Location

Lisbon, Portugal

Early cancer detection and the identification of reliable biomarkers for patient monitoring remain critical unmet needs in oncology. While many methods have struggled to deliver consistent or affordable solutions, proteomics can answer these challenges. 

 

Industry symposium:
Plasma Proteomics: Driving a New Era for Cancer Research and Precision Medicine

Date: June 18, 2025 | Time: 14:30 – 15:15 CEST | Room: Auditorium 2 

 

In this session, Stefan Enroth, PhD, will present how analyzing 5416 plasma proteins improved diagnostic accuracy in ovarian cancer, reducing the need for unnecessary biopsies by effectively identifying benign cases. 

Antoine Italiano, MD, PhD, will explore how plasma proteomics is advancing biomarker discovery and precision medicine in immuno-oncology, offering new insights into tumor-immune system interactions in clinical studies. 

Join our symposium and meet us at booth #89 to discover how proteomics is revolutionizing cancer research and its clinical translation to shape the future of precision medicine. 

Meet the speakers: 

Stefan Enroth, PhD

Talk title: Deep plasma proteomics identifies and validates an eight-protein biomarker panel for ovarian cancer. 

Antoine Italiano, MD, PhD 

Talk title: Liquid biopsy: Plasma proteomics to identify novel biomarkers